• 1
    Enzinger FM. Clear cell sarcoma of tendons and aponeuroses: an analysis of 21 cases. Cancer 1965; 18: 116374.
  • 2
    Eckardt JJ, Pritchard DJ, Soule EH. Clear cell sarcoma: a clinicopathologic study of 27 cases. Cancer 1983; 52: 14828.
  • 3
    Sara AS, Evans HL, Benjamin RS. Malignant melanoma of soft parts (clear cell sarcoma). A study of 17 cases, with emphasis on prognostic factors. Cancer 1990; 65: 36774.
  • 4
    Lucas DR, Nascimento AG, Sim FH. Clear cell sarcoma of soft tissues: Mayo clinic experience with 35 cases. Am J Surg Pathol 1992; 161: 197204.
  • 5
    Montgomery EA, Meis JM, Ramos AG, Frisman DM, Martz KL. Clear cell sarcoma of tendons and aponeuroses: a clinicopathological study of 58 cases with analysis of prognostic factors. Int J Surg Pathol 1993; 1: 89100.
  • 6
    Hajdu SI, Shiu MH, Fortner JG. Tendosynovial sarcoma: a clinicopathological study of 136 cases. Cancer 1977; 39: 120117.
  • 7
    Azumi N, Turner RR. Clear cell sarcoma of tendons and aponeuroses: electron microscopic findings suggesting Schwann cell differentiation. Hum Pathol 1983; 14: 108489.
  • 8
    Chung EB, Enzinger FM. Malignant melanoma of soft parts: a reassessment of clear cell sarcoma. Am J Surg Pathol 1983; 7: 40513.
  • 9
    Kindblom L-G, Lodding P, Angervall L. Clear-cell sarcoma of tendons and aponeuroses. Virchow Arch A 1983; 401; 10928.
  • 10
    Enzinger FM, Weiss SW. Clear cell sarcoma (Malignant melanoma of soft parts). In: EnzingerFM, WeissSW, eds. Soft tissue tumors, 3rd ed. St. Louis: Mosby Year Book, 1995. 91319.
  • 11
    Bearman RM, Noe JN, Kempson RL. Clear cell sarcoma with melanin pigment. Cancer 1975; 36: 97784.
  • 12
    Boudreaux D, Waisman J. Clear cell sarcoma with melanogenesis. Cancer 1978; 41: 138794.
  • 13
    Mechtersheimer G, Tilgen W, Klar E, Möller P. Clear cell sarcoma of tendons and aponeuroses: case presentation with special reference to immunohistochemical findings. Hum Pathol 1989; 20: 9147.
  • 14
    Graadt van Roggen JG, Mooi WJ, Hogendoorn PCW. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: exploring the histogenetic relationship between these two clinicopathological entities. J Pathol 1998; 186: 37.
  • 15
    Mitelman F, Johansson B, Mertens F, eds.
  • 16
    Dezmaze C, Zucman J, Delatre O, Melot T, Thomas G, Aurias A. Precise localization on chromosome 12 of the ATF-1 gene by fluorescence in situ hybridization. Hum Genet 1989; 93: 2078.
  • 17
    Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M, Kovar H, Joubert I, de Jong P, Rouleau G, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992; 359; 1624.
  • 18
    Zucman J, Delattre O, Desmaze C, Epstein AL, Stenman G, Speleman F, Fletchers CD, Aurias A, Thomas G. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 1993; 4: 3435.
  • 19
    Tomayko MM, Reynolds P. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24: 14854.
  • 20
    Bauer HCF, Brosjö O, Broström L-Å, Reinholt FP, Tribukait B. Growth and ploidy of human osteosarcoma xenografts in serial passage in nude mice. Eur J Cancer Clin Oncol 1986; 22: 82130.
  • 21
    Palmquist R, Öberg Å, Bergström C, Rutegård JN, Zackrisson B, Stenling R. Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer. Br J Cancer 1998; 77: 91725.
  • 22
    Steel GG. Growth kinetics of tumours. Oxford: Clarendon Press, 1977.
  • 23
    Wilson GD, McNally MC. Measurement of cell proliferation using bromodeoxyuridine. In: HallPA, ed. Assessment of cell proliferation in clinical practice. London: Springer, 1992. 11339.
  • 24
    Mandahl N, Heim S, Arheden K, Rydholm A, Willen H, Mitelman F. Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas. Hum Genet 1988; 79: 2038.
  • 25
    ISCN. An international system for human cytogenetic nomenclature. MitelmanF, ed. Karger Basel: ISCN, 1995.
  • 26
    Epstein AL, Martin AO, Kempson R. Use of a newly established human cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma. Cancer Res 1984; 44: 126574.
  • 27
    Sonobe H, Furihata M, Iwata J, Ohtsuki Y, Mizobuchi H, Yamamoto H, Kumano O. Establishment and characterization of a new human clear-cell sarcoma cell line, HS-MM. J Pathol 1993; 169: 31722.
  • 28
    Takenouchi T, Ito K, Kazama T, Ito M. Establishment and characterization of a clear-cell sarcoma (malignant melanoma of soft parts) cell line. Arch Dermatol Res 1994; 286: 25460
  • 29
    Hiraga H, Nojima T, Abe S, Yamashiro K, Yamawaki S, Kaneda K, Nagashima K. Establishment of a new continuous clear cell sarcoma cell line. Morphological and cytogenetic characterization and detection of chimaeric EWS/ATF-1 transcripts. Virchow Arch 1997; 431: 4551.
  • 30
    Sonobe H, Takeuchi T, Taguchi T, Shimizu K, Iwata J, Furihata M, Ohtsuki Y. Further characterization of the human clear cell sarcoma cell line HS-MM demonstrating a specific (t12;22)(q13;q12) translocation and hybrid EWS/ATF-1 transcript. J Pathol 1999; 187: 5947.
  • 31
    Berger DP, Winterhalter BR, Fiebig HH. Establishment and characterization of human tumor xenografts in thymus-aplastic nude mice. In: FiebigHH, BergerDP, eds. Immunodeficient mice in oncology. Contrib Oncol. Karger Basel, 1992. 2346.
  • 32
    Speleman F, Delattre O, Peter M, Hauben E, van Roy N, Van Marck E. Malignant melanoma of soft parts (clear cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation. Mod Pathol 1997; 10; 4969.
  • 33
    Pellin A, Monteagudo C, López-Ginés C, Carda C, Boix J, Llombart-Bosch A. New type of chimeric fusion product between the EWS and ATF1 genes in clear cell sarcoma (malignant melanoma of soft parts). Genes Chromosomes Cancer 1998; 23: 35860.
  • 34
    Johansson B, Fioretos T, Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 2002; 107; 7694.
  • 35
    Begg AC, McNally NJ, Shrieve DC, Karcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry 1985; 6: 6206.
  • 36
    Perez LA, Dombowski D, Efird J, Preffer F, Suit H. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements. Cancer Res 1995; 55: 3928.
  • 37
    Mooi WJ, Deenik W, Peterse JL, Hogendoorn PCW. Keratin immunoreactivity in melanoma of soft parts (clear cell sarcoma). Histopathology 1995; 27; 615.